Pular para o conteúdo
Merck
Todas as fotos(3)

Key Documents

GE17-3717-01

Capto S ImpAct

Cytiva 17-3717-01, pack of 25 ml

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Código UNSPSC:
23151817
NACRES:
NA.56

ligand

(-SO3)

fabricante/nome comercial

Cytiva 17-3717-01

matriz

high-flow agarose

Tamanho médio da partícula

50 μm (d50V)

cleaning in place

4-12

working range

3-14

capacidade

binding capacity(>85 mg BSA/mL medium, >90 mg lysozyme/ml medium, >100 mg IgG/ ml medium)

Procurando produtos similares? Visita Guia de comparação de produtos

Categorias relacionadas

Descrição geral

This chromatography medium is part of our platform of high-resolution media based on the Capto product line. The polymeric ligand, in combination with the attributes of the base matrix, gives this cation exchanger a high binding capacity. Furthermore, the small bead size enables high-resolution purifications.

The high-flow characteristics of Capto media allows for excellent pressure-flow properties. The exceptional binding capacity and resolution of Capto S ImpAct, combined with the ability to run at high flow rates and bed heights, increase productivity and flexibility in process design.

Capto S ImpAct is a BioProcess chromatography medium developed for large-scale purification of biopharmaceutical proteins. Based on the well-established Capto base matrix, it provides many opportunities for improved productivity and straightforward process development.

Capto S ImpAct is available in a range of different bulk pack sizes and convenient prepacked formats for easy scale-up and process development. As a member of the BioProcess media range, Capto S ImpAct meets industrial demands with security of supply and comprehensive technical and regulatory support.

Características e benefícios

Capto S ImpAct is a strong cation exchange chromatography medium (resin) developed for intermediate purification and polishing of monoclonal antibodies (MAbs) and other biomolecules.

  • High binding capacity, > 100 mg MAb/mL medium.
  • Efficient aggregate removal at high load of monoclonal antibodies.
  • High-resolution intermediate purification and polishing based on the well-established Capto platform.
  • Flexibility of design thanks to a large operational window of flow rates and bed heights for easy optimization and scaling.
  • High productivity enabling cost-efficient manufacturing.
  • Security of supply and comprehensive regulatory support.

Nota de análise

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Informações legais

Capto is a trademark of Cytiva

Código de classe de armazenamento

3 - Flammable liquids


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica